CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 27, 16:00
CureVac Enterprise Value : 601.60M for Feb. 27, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioNTech SE | 11.05B |
| Bayer AG | 88.13B |
| MediGene AG | -- |
| InflaRx NV | 11.01M |
| Immatics NV | 769.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 319.28M |
| Revenue (Quarterly) | 63.26M |
| Total Expenses (Quarterly) | -256.02M |
| EPS Diluted (Quarterly) | 1.414 |
| Gross Profit Margin (Quarterly) | 91.57% |
| Earnings Yield | 15.33% |
| Normalized Earnings Yield | 15.43 |